Glenmark Life SciencesGLS 
$12.47-0.24%24h
-0.24%24h
Global rank6156
Market cap$1.53B
Change 7d6.67%
YTD Performance58.63%
SP500 benchmarkOutperform
P/E0.33
P/S6.25
Revenue$244.33M
Earnings$55.71M
Dividend yield-
Main Sector
Healthcare
Category
Glenmark Life Sciences (GLS) Net Assets
GLS Net Assets in 2023: $21.38B
As of 26 Aug 2024, Glenmark Life Sciences net assets is $21.38B, an increase of 4.08% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Glenmark Life Sciences overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Glenmark Life Sciences Net Assets History from 2019 to 2024
-
Value:-
GLS Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $21.38B | 4.08% |
| 2022 | $20.54B | 172.91% |
| 2021 | $7.53B | 87.39% |
| 2020 | $4.02B | 20394.49% |
| 2019 | $19.60M | - |
View the Top Net Assets Companies
